GlassScriptPhysician profile
Jenifer Kaufmann Lehrer
NPI 1831153543
$3,160.07
in general payments reported to CMS, 2019-2025
18 companies · $16.81 in 2025
The $16.81 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,263 · 2020: $491 · 2021: $864 · 2022: $462 · 2023: $63.63 · 2025: $16.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $80.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $80.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $982.36 | 2019-2022 | |
| Abbvie INC. | $634.96 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $591.50 | 2019-2022 | |
| Janssen Biotech, INC. | $403.34 | 2019-2022 | |
| Gilead Sciences, INC. | $112.64 | 2019-2022 | |
| Braintree Laboratories, INC. | $93.49 | 2020-2022 | |
| Redhill Biopharma INC. | $61.41 | 2020 | |
| Pfizer INC. | $54.49 | 2021 | |
| Ironwood Pharmaceuticals, INC | $47.93 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $43.90 | 2019-2022 | |
| Boston Scientific Corporation | $25.21 | 2023 | Watchman Access System |
| Dova Pharmaceuticals | $21.76 | 2019 | |
| Allergan, INC. | $18.59 | 2019 | |
| Glaxosmithkline, LLC. | $16.81 | 2025 | Ojjaara |
| Merck Sharp & Dohme LLC | $16.46 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nestle Healthcare Nutrition INC. | $12.44 | 2021 | |
| Celgene Corporation | $11.80 | 2022 | |
| Intra-Sana Laboratories | $10.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenifer Lehrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.